title: Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin.
abstract: Mutations in the myostatin gene are associated with hypermuscularity, suggesting that myostatin inhibits skeletal muscle growth. We postulated that increased tissue-specific expression of myostatin protein in skeletal muscle would induce muscle loss. To investigate this hypothesis, we generated transgenic mice that overexpress myostatin protein selectively in the skeletal muscle, with or without ancillary expression in the heart, utilizing cDNA constructs in which a wild-type (MCK/Mst) or mutated muscle creatine kinase (MCK-3E/Mst) promoter was placed upstream of mouse myostatin cDNA. Transgenic mice harboring these MCK promoters linked to enhanced green fluorescent protein (EGFP) expressed the reporter protein only in skeletal and cardiac muscles (MCK) or in skeletal muscle alone (MCK-3E). Seven-week-old animals were genotyped by PCR of tail DNA or by Southern blot analysis of liver DNA. Myostatin mRNA and protein, measured by RT-PCR and Western blot, respectively, were significantly higher in gastrocnemius, quadriceps, and tibialis anterior of MCK/Mst-transgenic mice compared with wild-type mice. Male MCK/Mst-transgenic mice had 18-24% lower hind- and forelimb muscle weight and 18% reduction in quadriceps and gastrocnemius fiber cross-sectional area and myonuclear number (immunohistochemistry) than wild-type male mice. Male transgenic mice with mutated MCK-3E promoter showed similar effects on muscle mass. However, female transgenic mice with either type of MCK promoter did not differ from wild-type controls in either body weight or skeletal muscle mass. In conclusion, increased expression of myostatin in skeletal muscle is associated with lower muscle mass and decreased fiber size and myonuclear number, decreased cardiac muscle mass, and increased fat mass in male mice, consistent with its role as an inhibitor of skeletal muscle mass. The mechanism of gender specificity remains to be clarified.
authors.affiliation: Division of Endocrinology, Metabolism and Molecular Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Reisz-Porszasz
authors.forename: Shalender
authors.initials: S
authors.lastname: Bhasin
authors.forename: Jorge N
authors.initials: JN
authors.lastname: Artaza
authors.forename: Ruoqing
authors.initials: R
authors.lastname: Shen
authors.forename: Indrani
authors.initials: I
authors.lastname: Sinha-Hikim
authors.forename: Aimee
authors.initials: A
authors.lastname: Hogue
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Fielder
authors.forename: Nestor F
authors.initials: NF
authors.lastname: Gonzalez-Cadavid
mesh_terms: D000818:Animals; D005260:Female; D008297:Male; D051379:Mice; D008822:Mice, Transgenic / Q000254:growth & development / Q000378:metabolism; D018482:Muscle, Skeletal / Q000254:growth & development* / Q000378:metabolism / Q000502:physiology; D055435:Myostatin; D009929:Organ Size; D009928:Organ Specificity; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012737:Sex Factors; D016212:Transforming Growth Factor beta / Q000235:genetics* / Q000378:metabolism*
chemical_list: C525912:Mstn protein, mouse; D055435:Myostatin; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta